top of page

Advancing EBV Research: Harnessing LEXSY technology for BGLF4 protein kinase expression and discovery

16 giu
Tempo di lettura: 1 min

LEXSY technology offers an efficient and scalable platform for expressing viral replication proteins, facilitating advanced research and vaccine development. 




 
 
 

Commenti


logo Elettrofor

CONTATTACI

0425 474533

comm@elettrofor.it

Via della Cooperazione, 38-40
45100 Borsea (Ro) Italy

© 2026 ELETTROFOR SAS | P.IVA 00950300293 | n. REA 105271

bottom of page